PT1154785E - Inibidores para utilizacao em hemostase e na funcao imunitaria - Google Patents

Inibidores para utilizacao em hemostase e na funcao imunitaria

Info

Publication number
PT1154785E
PT1154785E PT00907310T PT00907310T PT1154785E PT 1154785 E PT1154785 E PT 1154785E PT 00907310 T PT00907310 T PT 00907310T PT 00907310 T PT00907310 T PT 00907310T PT 1154785 E PT1154785 E PT 1154785E
Authority
PT
Portugal
Prior art keywords
hemostase
inhibitors
immune function
related protein
complement related
Prior art date
Application number
PT00907310T
Other languages
English (en)
Inventor
Paul D Bishop
Gerald Lasser
Paul O Sheppard
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of PT1154785E publication Critical patent/PT1154785E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
PT00907310T 1999-02-19 2000-02-17 Inibidores para utilizacao em hemostase e na funcao imunitaria PT1154785E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25360499A 1999-02-19 1999-02-19
US44479499A 1999-11-22 1999-11-22

Publications (1)

Publication Number Publication Date
PT1154785E true PT1154785E (pt) 2003-12-31

Family

ID=26943406

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00907310T PT1154785E (pt) 1999-02-19 2000-02-17 Inibidores para utilizacao em hemostase e na funcao imunitaria

Country Status (20)

Country Link
US (1) US6448221B1 (pt)
EP (2) EP1382345A3 (pt)
JP (1) JP2002537270A (pt)
KR (1) KR20010102130A (pt)
CN (1) CN1341027A (pt)
AT (1) ATE245439T1 (pt)
AU (1) AU772103B2 (pt)
BR (1) BR0008298A (pt)
CA (1) CA2361273A1 (pt)
CZ (1) CZ20012916A3 (pt)
DE (1) DE60004015T2 (pt)
DK (1) DK1154785T3 (pt)
ES (1) ES2202061T3 (pt)
HK (1) HK1039892A1 (pt)
HU (1) HUP0105284A3 (pt)
IL (1) IL144460A0 (pt)
NO (1) NO20014012L (pt)
PL (1) PL349924A1 (pt)
PT (1) PT1154785E (pt)
WO (1) WO2000048625A2 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525174B1 (en) 1997-06-06 2003-02-25 Human Genome Sciences, Inc. Precerebellin-like protein
US20040014650A1 (en) * 2002-07-17 2004-01-22 Sheppard Paul D Methods for enhancing wound repair
US6544946B1 (en) * 1999-02-19 2003-04-08 Zymogenetics, Inc. Inhibitors for use in hemostasis and immune function
US8236048B2 (en) 2000-05-12 2012-08-07 Cordis Corporation Drug/drug delivery systems for the prevention and treatment of vascular disease
MY128992A (en) * 2000-08-25 2007-03-30 Merck Patent Gmbh Saratin for inhibiting platelet adhesion to collagen
CA2424029C (en) 2000-09-29 2008-01-29 Cordis Corporation Coated medical devices
US20030220253A1 (en) * 2002-03-08 2003-11-27 Lasser Gerald W. Inhibitors for use in hemostasis
NO20035748D0 (no) * 2003-12-19 2003-12-19 Amersham Health As Optisk avbildning av sårbar arteriosklerose
US9471978B2 (en) 2004-10-04 2016-10-18 Banner Health Methodologies linking patterns from multi-modality datasets
WO2006104964A2 (en) * 2005-03-28 2006-10-05 University Of Louisville Research Foundation, Inc. Inhibition of wet type age related macular degeneration (amd) by adiponectin or acrp 30
US20090291091A1 (en) * 2005-07-29 2009-11-26 Laboratoires Serono Sa Use of the globular domain of acrp30 for the preparation of a medicament for the prevention and/or treatment of thrombosis-related diseases
WO2008075589A1 (ja) * 2006-12-21 2008-06-26 Chisso Corporation 血小板凝集惹起物質
JP5747370B2 (ja) * 2009-03-31 2015-07-15 国立大学法人浜松医科大学 高病原性口腔細菌の高感度検出法
WO2023215294A1 (en) * 2022-05-02 2023-11-09 The Board Of Trustees Of The Leland Stanford Junior University Complement pathway inhibition for wound healing

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869330A (en) * 1995-06-05 1999-02-09 Whitehead Institute For Biomedical Research DNA encoding a novel serum protein produced exclusively in adipocytes
EP1000084A4 (en) 1997-07-08 2003-03-26 Human Genome Sciences Inc 123 PROTEIN SEPARATED BY HUMAN
BR9810917A (pt) 1997-07-18 2000-08-15 Zymogenetics Inc Polipeptìdeo isolado, proteìna de fusão, vetor de expressão, célula cultivada, processo para produzir um polipeptìdeo, composição farmacêutica, anticorpo, proteìna de ligação, polinucleotìdeo isolado, e, sonda de oligonucleotìdeo ou iniciador
WO1999006551A2 (en) 1997-08-01 1999-02-11 Genset 5' ESTs FOR SECRETED PROTEINS IDENTIFIED FROM BRAIN TISSUES
AU744254B2 (en) 1997-08-26 2002-02-21 Zymogenetics Inc. Adipocyte-specific protein homologs
DK1033134T3 (da) 1997-10-29 2007-07-16 Otsuka Pharma Co Ltd Sammensætninger, som inhiberer proliferation af glat muskel, og fremgangsmåde til diagnosticering af arteriosklerose
NZ527900A (en) 1997-12-03 2005-02-25 Genentech Inc PRO361 polypeptides and nucleic acids with homology to mucin and chitinase
JP2002511231A (ja) 1997-12-30 2002-04-16 カイロン コーポレイション 骨髄分泌タンパク質およびポリヌクレオチド
ID27813A (id) 1998-01-28 2001-04-26 Corixa Corp Senyawa-senyawa untuk terapi dan diagnosa kanker paru-paru dan metoda untuk penggunaannya
NZ507728A (en) 1998-04-29 2002-06-28 Genesis Res & Dev Corp Ltd Information from a cDNA library created from keratinocytes, dermal papilla, neonatal foreskin fibroblast or embryonic skin cells is used to treating cancer, angiogenesis, skin inflammation, inflammatory diseases or stimulating keratinocyte growth
EP1085897A4 (en) 1998-05-21 2003-03-12 Smithkline Beecham Corp ACRP30R1L, ACRP30 APPROVED (PROTEIN ASSOCIATED WITH A 30 KD ADIPOCYTE COMPLEMENT)

Also Published As

Publication number Publication date
HK1039892A1 (zh) 2002-05-17
WO2000048625A2 (en) 2000-08-24
NO20014012D0 (no) 2001-08-17
WO2000048625A3 (en) 2000-12-28
CN1341027A (zh) 2002-03-20
AU772103B2 (en) 2004-04-08
US6448221B1 (en) 2002-09-10
CZ20012916A3 (cs) 2002-05-15
AU2883200A (en) 2000-09-04
EP1154785B1 (en) 2003-07-23
PL349924A1 (en) 2002-10-21
EP1382345A2 (en) 2004-01-21
CA2361273A1 (en) 2000-08-24
NO20014012L (no) 2001-10-02
HUP0105284A3 (en) 2003-12-29
HUP0105284A2 (hu) 2002-05-29
ATE245439T1 (de) 2003-08-15
JP2002537270A (ja) 2002-11-05
DK1154785T3 (da) 2003-11-17
EP1154785A2 (en) 2001-11-21
DE60004015D1 (de) 2003-08-28
ES2202061T3 (es) 2004-04-01
BR0008298A (pt) 2002-02-19
EP1382345A3 (en) 2004-01-28
DE60004015T2 (de) 2004-04-15
IL144460A0 (en) 2002-05-23
KR20010102130A (ko) 2001-11-15

Similar Documents

Publication Publication Date Title
PT1154785E (pt) Inibidores para utilizacao em hemostase e na funcao imunitaria
DE60236413D1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
DK0698108T3 (da) Adenovirale vektorer af animalsk oprindelse og deres anvendelse ved genterapi
DE69118535D1 (de) Osteo-induktive pharmazeutische formulierungen
AU5056196A (en) Hydrogel-forming, self-solvating absorbable polyester copolymers and methods for use thereof
PT755249E (pt) Utilizacao de inibidores da reaccao de maillard para o tratamento de doenca com base em amiloidose
ATE401343T1 (de) Tolerogenische peptide
ES2123134T3 (es) Peptidos biologicamente activos de dominios funcionales de la proteina bactericida aumentadora de la permeabilidad y usos de los mismos.
BR9812357A (pt) Tratamento de distúbio oposicional desafiador
IT1296954B1 (it) Chiodo endomidollare per uso in osteosintesi per il trattamento chirurgico delle fratture diafisometafisarie di femore e di tibia,
ATE245977T1 (de) Therapeutische substituierte guanidine
IS5591A (is) Grunnmassaprótínsamsetningar til sáragræðslu
DK0643585T3 (da) Anvendelsen af lipoprotein-associeret koagulationsinhibitor (LACI) til fremstilling af et lægemiddel til behandlingen af ak
GB9930768D0 (en) Composition
EA200200853A1 (ru) Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen
DE60011601D1 (de) Rekombinantes sp-a zur behandlung und vorbeugung von pulmonaren infektionen und entzündungen
ID23176A (id) Metoda untuk mengobati gangguan pembuluh darah
PT661058E (pt) Utilizacao de antagonistas da bradiquinina para o tratamento de doencas virais
DE50207168D1 (de) Kombinationspräparat zur Therapie von immunologischen Erkrankungen
GEP19991605B (en) Inhibitor, Its Obtaining and Use
UA37445A (uk) Протизапальний засіб
DK0895478T3 (da) Bestanddel B som ardanner
BR9400411A (pt) Medicamento para tratamento de dilacerações traumatismos infecções deversas e assepsias
UA9703A (uk) Антипротеіназний засіб